Alcon, Inc. Market Share Analysis

  • February 2013
  • -
  • Global Data
  • -
  • 224 pages

Alcon, Inc. Market Share Analysis



Summary



GlobalData’s new report, “Alcon, Inc. Market Share Analysis” provides in-depth information on Alcon, Inc.’s market position in the different medical equipment markets it operates in. The report provides Alcon, Inc. market share information in six key market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Intraocular Lens (IOL), Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.



Scope


- Global company shares (in Revenues) information for the key markets Alcon, Inc. operates in –Ophthalmic Devices.
- Alcon, Inc.’s company shares (in Revenues) information for all the key countries the company has presence in – Australia, Spain, France, Germany, Italy, United Kingdom, India, United States, Japan, Canada, China and Brazil.
- Alcon, Inc.’s company shares (in Revenues) information for all the key market categories the company has presence in – Cataract Surgery Devices, Glaucoma Surgery Devices, Intraocular Lens (IOL), Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices.
- All the key data-points are for 2011 and cover all the key regions – North America, Europe, Asia Pacific (APAC), South and Central America and Middle East and Africa.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.



Reasons to buy


- Develop sales and marketing strategies by identifying who-stands-where in the markets, Alcon, Inc. operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Alcon, Inc.’s market positions.

Table Of Contents

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 12
2 Introduction 14
2.1 What Is This Report About? 14
3 Definitions of Markets/Categories Covered 15
3.1 Ophthalmic Devices 15
3.1.1 Cataract Surgery Devices 15
3.1.2 Glaucoma Surgery Devices 15
3.1.3 Intraocular Lens (IOL) 15
3.1.4 Refractive Surgery Devices 15
3.1.5 Vision Care 15
3.1.6 Vitreo Retinal Surgery Devices 15
4 Company Snapshot 16
4.1 Key Information 16
4.2 Company Overview 16
4.3 SWOT Snapshot 16
4.4 Business Overview 17
4.5 Major Products and Services 18
4.5.1 Overview 18
5 History 19
6 SWOT Analysis 23
6.1 Overview 23
6.2 Alcon, Inc. Strengths 23
6.2.1 Strong Financial Capabilities 23
6.2.2 Market Leadership 24
6.2.3 Diversified Geographical Presence 24
6.3 Alcon, Inc. Weaknesses 24
6.3.1 Decrease in Cash Reserves 24
6.3.2 Patent Infringement Lawsuits 24
6.4 Alcon, Inc. Opportunities 25
6.4.1 Emerging Markets 25
6.4.2 Growing Aged Population 25
6.4.3 Global Ophthalmic Devices Market 25
6.4.4 Inorganic Growth Drivers 26
6.4.5 New Product Launches and Strong Pipeline 26
6.5 Alcon, Inc. Threats 26
6.5.1 Uncertain RandD Outcomes 26
6.5.2 Regulatory Requirements 26
6.5.3 Cost Containment Pressures 26
6.5.4 Industry Consolidation 27
6.5.5 Intense Competition 27
7 Competitors 28
8 Competitive Landscape 29
8.1 Ophthalmic Devices (Cataract Surgery Devices), Global, Market Share (%), 2011 29
8.2 Alcon, Inc., Ophthalmic Devices (Cataract Surgery Devices), by Region, Market Share (2011) 30
8.3 Alcon, Inc., Ophthalmic Devices (Cataract Surgery Devices), by Country, Market Share (2011) 31
8.4 Ophthalmic Devices (Glaucoma Surgery Devices), Global, Market Share (%), 2011 33
8.5 Alcon, Inc., Ophthalmic Devices (Glaucoma Surgery Devices), by Region, Market Share (2011) 34
8.6 Alcon, Inc., Ophthalmic Devices (Glaucoma Surgery Devices), by Country, Market Share (2011) 35
8.7 Ophthalmic Devices (Intraocular Lens (IOL)), Global, Market Share (%), 2011 37
8.8 Alcon, Inc., Ophthalmic Devices (Intraocular Lens (IOL)), by Region, Market Share (2011) 38
8.9 Alcon, Inc., Ophthalmic Devices (Intraocular Lens (IOL)), by Country, Market Share (2011) 39
8.10 Ophthalmic Devices (Refractive Surgery Devices), Global, Market Share (%), 2011 41
8.11 Alcon, Inc., Ophthalmic Devices (Refractive Surgery Devices), by Region, Market Share (2011) 43
8.12 Alcon, Inc., Ophthalmic Devices (Refractive Surgery Devices), by Country, Market Share (2011) 44
8.13 Ophthalmic Devices (Vision Care), Global, Market Share (%), 2011 46
8.14 Alcon, Inc., Ophthalmic Devices (Vision Care), by Region, Market Share (2011) 47
8.15 Alcon, Inc., Ophthalmic Devices (Vision Care), by Country, Market Share (2011) 48
8.16 Ophthalmic Devices (Vitreo Retinal Surgery Devices), Global, Market Share (%), 2011 50
8.17 Alcon, Inc., Ophthalmic Devices (Vitreo Retinal Surgery Devices), by Region, Market Share (2011) 51
8.18 Alcon, Inc., Ophthalmic Devices (Vitreo Retinal Surgery Devices), by Country, Market Share (2011) 52
9 Alcon, Inc. Medical Equipment Market Share Analysis 54
9.1 Alcon, Inc., Ophthalmic Devices, Global, Category Revenue Share (2011) 54
9.2 Alcon, Inc., Asia-Pacific, Category Revenue Share (2011) 56
9.2.1 Alcon, Inc., Australia, Category Revenue Share (2011) 58
9.2.2 Alcon, Inc., China, Category Revenue Share (2011) 60
9.2.3 Alcon, Inc., India, Category Revenue Share (2011) 62
9.2.4 Alcon, Inc., Japan, Category Revenue Share (2011) 64
9.2.5 Alcon, Inc., Other Asia-Pacific, Category Revenue Share (2011) 66
9.3 Alcon, Inc., Europe, Category Revenue Share (2011) 68
9.3.1 Alcon, Inc., France, Category Revenue Share (2011) 70
9.3.2 Alcon, Inc., Germany, Category Revenue Share (2011) 72
9.3.3 Alcon, Inc., Italy, Category Revenue Share (2011) 74
9.3.4 Alcon, Inc., Spain, Category Revenue Share (2011) 76
9.3.5 Alcon, Inc., United Kingdom, Category Revenue Share (2011) 78
9.3.6 Alcon, Inc., Other Europe, Category Revenue Share (2011) 80
9.4 Alcon, Inc., Middle East and Africa, Category Revenue Share (2011) 82
9.5 Alcon, Inc., North America, Category Revenue Share (2011) 84
9.5.1 Alcon, Inc., Canada, Category Revenue Share (2011) 86
9.5.2 Alcon, Inc., United States, Category Revenue Share (2011) 88
9.6 Alcon, Inc., South and Central America, Category Revenue Share (2011) 90
9.6.1 Alcon, Inc., Brazil, Category Revenue Share (2011) 92
9.6.2 Alcon, Inc., Other South and Central America, Category Revenue Share (2011) 94
10 Key Employees 96
11 Key Employee Biographies 97
12 Locations And Subsidiaries 98
12.1 Head Office 98
12.2 Other Locations and Subsidiaries 98
13 Financial Deals Landscape 103
13.1 Alcon, Inc., Deals Volume Summary, 2007 to 2012 103
14 Alcon, Inc., Deals Summary By Region, 2007 to 2012 104
15 Alcon, Inc. Detailed Deal Summary 106
15.1 Partnerships 106
15.1.1 IRIDEX Enters Into Licensing Agreement With Alcon 106
15.1.2 Alcon Enters Into Licensing Agreement With Advanced Medical Optics 107
15.1.3 Advanced Medical Optics Enters Into Licensing Agreement With Alcon 108
15.2 Acquisition 109
15.2.1 Novartis Completes Acquisition Of Remaining 23% Stake In Alcon 109
15.2.2 Novartis Completes Acquisition Of Additional 52% Stake In Alcon From Nestle 111
15.2.3 Alcon Completes Acquisition Of Optonol 114
15.2.4 Alcon Acquires Additional 17.6% Stake In WaveLight 116
15.2.5 Novartis Acquires 25% Stake In Alcon From Nestle 117
16 Recent Developments 119
16.1 Strategy And Business Planning 119
16.1.1 Dec 14, 2009: Alcon To Enter Surgical Glaucoma Market By Acquiring Optonol 119
16.1.2 Oct 23, 2009: Potentia Seals Licensing, Purchase Option Agreements With Alcon 119
16.1.3 Jul 22, 2009: Alcon Signs Agreement With AstraZeneca On Eye Drug Development 120
16.1.4 May 25, 2009: Alcon Begins Construction Of Manufacturing Plant In Singapore 120
16.1.5 Feb 11, 2009: Alcon To Cut 260 Work Force 121
16.1.6 Sep 19, 2008: Alcon Announces Expansion Plan In West Virginia 121
16.1.7 Sep 10, 2007: Alcon To Expand Swiss Operations 122
16.2 Financial Announcements 122
16.2.1 Jan 27, 2011: Alcon Reports Sales Of $7.17 Billion In 2010 122
16.2.2 Oct 20, 2010: Alcon Reports Net Income Of $446 Million For Q3 2010 123
16.2.3 Jul 26, 2010: Alcon Reports Net Earnings Of $670 Million In Q2 2010 124
16.2.4 Apr 26, 2010: Alcon Reports Net Earnings Of $573 Million In Q1 2010 125
16.2.5 Feb 11, 2010: Alcon Reports Net Earnings Of $2 Billion In 2009 126
16.2.6 Oct 27, 2009: Alcon Reports Net Earnings Of $515 Million In Q3 2009 128
16.2.7 Jul 22, 2009: Alcon Posts Net Earnings Of $582 Million For Q2 2009 130
16.2.8 Jul 22, 2009: Alcon Reports Strong Financial Results For Second Quarter 131
16.2.9 Apr 22, 2009: Alcon Posts Net Earnings Of $452 Million For Q1 2009 131
16.2.10 Feb 11, 2009: Alcon Reports 2008 Results 133
16.2.11 Jan 08, 2009: Alcon To Declare 2008 Results 134
16.2.12 Oct 22, 2008: Alcon Reports 3Q 2008 Results 135
16.2.13 Oct 22, 2008: Alcons Third Quarter Sales Rise 14.1 Percent 137
16.2.14 Oct 01, 2008: Alcon To Declare 3Q 2008 Results 138
16.2.15 Jul 23, 2008: Alcon Reports 2Q 2008 Results 139
16.2.16 Jul 23, 2008: Alcons Second Quarter Sales Rise 17.9 Percent; Net Earnings Increase 26.3 Percent 141
16.2.17 Jun 17, 2008: Alcon To Declare Q2 2008 Results 143
16.2.18 May 06, 2008: Alcon Approves Dividend 143
16.2.19 Apr 23, 2008: Alcon Declares Q1 2008 Results 143
16.2.20 Apr 23, 2008: Alcons First Quarter Sales Rise 16.2 Percent; Net Income Increases 24.0 Percent 145
16.2.21 Mar 28, 2008: Alcon To Declare Q1 2008 Results 145
16.2.22 Feb 06, 2008: Alcon Declares Q4 2007 Results 146
16.2.23 Feb 06, 2008: Alcons Fourth Quarter Sales Rise 20.0 Percent 147
16.2.24 Oct 24, 2007: Alcons Third Quarter Sales Rise 11.0 Percent 149
16.2.25 Oct 24, 2007: Alcon Declares Q3 2007 Results 151
16.2.26 Jul 25, 2007: Alcon Declares Q2 2007 Results 152
16.2.27 Jul 25, 2007: Alcons Second Quarter Sales Rise 12.3 Percent 154
16.2.28 May 09, 2007: Alcon Approves Dividend 155
16.2.29 Apr 25, 2007: Alcon's Q1 Global Sales Up By 14.3% 155
16.2.30 Apr 25, 2007: Alcons First Quarter Sales Rise 14.3 Percent 157
16.2.31 Mar 26, 2007: Alcon Announces Q1 2007 Financial Release Date 159
16.2.32 Feb 07, 2007: Alcon Declares Q4 2006 Results 159
16.2.33 Feb 07, 2007: Alcons Fourth Quarter Sales Rise 16.1 Percent 161
16.2.34 Oct 23, 2006: Alcons Third Quarter Sales Rise 12.4 Percent 163
16.2.35 Oct 23, 2006: Alcon's Q3 Global Sales Up By 12.4% 165
16.2.36 Sep 18, 2006: Alcon Announces Q3 2006 Financial Release Date 166
16.2.37 Sep 08, 2006: Alcon Approves Repurchase Of 5 Million Additional Shares 167
16.2.38 Jul 24, 2006: Alcon's Q2 Global Sales Up 11.8% To $1,310.8 Million 167
16.2.39 Jul 24, 2006: Alcons Second Quarter Sales Rise 11.8 Percent 169
16.2.40 Jun 19, 2006: Alcon Announces Q2 2006 Financial Release Date 169
16.2.41 May 02, 2006: Alcon Approves Dividend 170
16.2.42 Apr 24, 2006: Alcons First Quarter Sales Rise 8.1 Percent, Net Earnings Increase 18.5 Percent 170
16.2.43 Feb 08, 2006: Alcons Fourth Quarter Sales Rise 10.7 Percent 172
16.2.44 Oct 19, 2005: Alcon’s Third Quarter Earnings Rise 52.2 Percent On 11.8 Percent Sales Growth 174
16.2.45 Jul 27, 2005: Alcons Second Quarter Sales Increase 12.8 Percent 175
16.2.46 Apr 21, 2005: Alcon’s First Quarter Earnings Rise 30.6 Percent On 11.1 Percent Sales Growth 176
16.2.47 Feb 09, 2005: Alcons Fourth Quarter Earnings Rise 39.9 Percent On 11.9 Percent Sales Growth 177
16.2.48 Oct 20, 2004: Alcons Third Quarter Earnings Rise 26.9 Percent On 16.5 Percent Sales Growth 180
16.2.49 Jul 28, 2004: Alcons Second Quarter Earnings Rise 67.9 Percent On 12.3 Percent Sales Growth 180
16.2.50 Jul 13, 2004: Alcon Provides Estimate Of Second Quarter Earnings 180
16.2.51 Apr 20, 2004: Alcons First Quarter Earnings Rise 46.7 Percent On 19.4 Percent Sales Growth 181
16.2.52 Feb 11, 2004: Alcons Fourth Quarter Sales Grow 13.7 Percent 182
16.2.53 Oct 22, 2003: Alcons Third-Quarter Earnings Rise 22.4 Percent As Sales Increase 10.6 Percent 184
16.2.54 Jul 30, 2003: Alcon Reports Strong Second Quarter And Six Month 2003 Results 186
16.2.55 Apr 22, 2003: Alcons First Quarter Net Earnings Rose 38.5% On 14.2% Sales Increase 188
16.2.56 Feb 19, 2003: Alcon Reports Strong Fourth Quarter And Full Year 2002 Results 190
16.2.57 Oct 24, 2002: Alcon Reports Third Quarter Operating Results 192
16.2.58 Jul 31, 2002: Alcon Reports Second Quarter Operating Results 194
16.2.59 May 02, 2002: Alcon Reports 17.9 Percent Increase in First Quarter Earnings Per Share 196
16.2.60 Apr 10, 2002: Alcon Posts First Quarter Sales Of $706.5 Million 197
16.3 Research And Development 198
16.3.1 Oct 26, 2009: Potentia Pharmaceuticals Enters Into Licensing, Purchase Option Agreements With Alcon 198
16.3.2 Jul 22, 2009: Alcon Signs Agreement With AstraZeneca On Eye Drug Development 198
16.3.3 Jun 22, 2009: Alcon Collaborates With AstraZeneca For Eye Drug Development 199
16.3.4 Oct 14, 2008: Alcon Signs Agreements With GSK and Origenis 199
16.3.5 Sep 19, 2008: Alcon To Expand Manufacturing Facility In West Virginia 200
16.4 Corporate Communications 200
16.4.1 Oct 24, 2010: Alcon Elects Daniel Vasella As New Chairman 200
16.4.2 Oct 04, 2010: Alcon Names Robert Karsunky As Senior Vice President, CFO 201
16.4.3 Oct 04, 2010: Alcon Appoints Robert Karsunky As CFO 201
16.4.4 Aug 16, 2010: Alcon Conditionally Elects Novartis-Designated Directors 202
16.4.5 May 05, 2009: Alcon Announces Board Appointments 202
16.4.6 Jan 08, 2009: Alcon Announces Executive Changes 203
16.4.7 Jan 08, 2009: Alcon Appoints Kevin Buehler As President, CEO 204
16.4.8 May 06, 2008: Alcon Announces Board Changes 204
16.4.9 Mar 10, 2008: Alcon Announces Management Changes 205
16.4.10 Sep 10, 2007: Alcon Senior Vice President To Retire 205
16.4.11 Jul 16, 2007: Alcon Appoints New CFO 205
16.4.12 Jun 26, 2007: Alcon CFO To Leave 205
16.4.13 May 09, 2007: Alcon Elects Board Members 206
16.4.14 May 02, 2006: Alcon Elects Board Members 206
16.5 Legal and Regulatory 206
16.5.1 Apr 30, 2010: Simmons Announces Settlement Of Contingent Fee Antitrust Lawsuit 206
16.5.2 Jun 26, 2007: Bausch and Lomb Files Suit Against Alcon 207
16.5.3 Jul 10, 2006: AMO Announces Patent Infringement Settlement With Alcon 207
16.5.4 Apr 05, 2006: Alcon Files Patent Infringement Suit Against Teva Pharmaceuticals 207
16.5.5 Dec 16, 2005: Alcon Will Appeal Ruling In Patent Case 208
16.5.6 May 06, 2005: Alcon Will Challenge Verdict In Patent Case 208
16.5.7 Dec 16, 2003: Alcon Views Amo Patent Lawsuit As Meritless 209
16.5.8 Dec 20, 2002: Alcon To Appeal Judges Vacating Jury Verdict Against Nidek 209
16.5.9 Oct 09, 2002: Alcon, Pharmacia Settle Intellectual Property Lawsuit 209
16.5.10 Sep 25, 2002: Alcon Victorious In Patent Lawsuit 210
16.6 Government and Public Interest 210
16.6.1 Jun 10, 2008: FDA Panel Recommends Stricter Contact Lens Labeling 210
16.7 Product News 211
16.7.1 Oct 04, 2012: Alcon’s LenSx Laser Receives FDA Clearance For Corneal Flap Creation In Corneal Refractive Procedures 211
16.7.2 Jul 19, 2012: TLC To Perform First Cataract Surgery Using Alcon’s LenSx Laser In Canada 212
16.7.3 Aug 16, 2011: NVISION Laser Eye Centers Announces Laser Refractive Cataract Surgery With Alcon’s LenSx Laser 212
16.7.4 Apr 25, 2011: Rockland Eye Physicians Use Alcon's AcrySof IQ ReSTOR IOL To Correct Cataracts Without Glasses 213
16.7.5 Dec 06, 2010: Alcon Gains FDA Approval To Complete Voluntary Medical Device Corrective Action Plan For Its CONSTELLATION Vision System 213
16.7.6 Sep 03, 2010: Alcon Launches AcrySof IQ ReSTOR Toric Intraocular Lens Outside US 214
16.7.7 Jul 22, 2010: Alcon Announces Class I Recall Of CONSTELLATION Vision System 214
16.7.8 Dec 23, 2008: Alcon Announces FDA Approval For Its AcrySof IQ ReSTOR +3.0 D Intraocular Lens 214
16.7.9 Sep 15, 2008: Alcon Launches New AcrySof ReSTOR Intraocular Lens For Presbyopia Outside The US 215
16.7.10 Sep 12, 2008: Alcon Expands Refractive Surgery Options With The Introduction Of The AcrySof Phakic Intraocular Lens Outside The US 215
16.7.11 Jun 25, 2008: Alcon Enters Into Patent Cross-Licensing Agreement With AMO 215
16.7.12 Feb 01, 2007: Alcon's AcrySof ReSTOR Apodized Diffractive Aspheric Intraocular Lens approved by FDA 216
16.7.13 Dec 18, 2006: Alcon Recalls 'Systane Free' Eye Drops 216
16.7.14 Dec 15, 2006: (ACL) Announces Voluntary Recall Of Systane(R) Free LIQUID GEL Lubricant Eye Drops In The United States, Including Puerto Rico. 216
16.7.15 Oct 25, 2006: Children’s Hospital of Austin is Helping Save Young Patients’ Eyesight with New Technology. 216
16.7.16 Jun 02, 2006: Alcon gets U.S. FDA approval for Ladar6000 Excimer Laser, Wavefront-Guided Hyperopia. 217
16.7.17 May 21, 2006: AcrySof IQ IOL Designated as a New Technology Intraocular Lens 217
16.7.18 Oct 12, 2005: FDA Approves Alcon's OPTI-FREE RepleniSH MPDS 217
16.7.19 Jan 15, 2005: Combination system provides extra protection. 217
16.7.20 Mar 01, 2004: Surgeons laud various advantages of viscoelastic duo. 217
16.7.21 Feb 28, 2003: What's Coming in 2003 217
16.7.22 Oct 24, 2002: Alcon Reports Third Quarter Operating Results 218
16.8 Product Approvals 218
16.8.1 Dec 23, 2008: Alcon Announces FDA Approval For Its AcrySof IQ ReSTOR +3.0 D Intraocular Lens 218
16.8.2 Feb 01, 2007: Alcon's AcrySof ReSTOR Apodized Diffractive Aspheric Intraocular Lens approved by FDA 218
16.8.3 Feb 01, 2007: Alcon's AcrySof ReSTOR Apodized Diffractive Aspheric Intraocular Lens Approved By FDA 218
16.8.4 Oct 12, 2005: FDA Approves Alcon's OPTI-FREE RepleniSH MPDS 219
16.9 Other Significant Developments 219
16.9.1 May 25, 2009: Alcon begins construction of its first pharmaceutical manufacturing plant in Asia 219
16.9.2 Sep 11, 2008: Alcon Plans To Invest EUR21 million At Its Cork City Plant 219
16.9.3 Jun 20, 2008: Alcon Laboratories Spends $0.24 Million On Lobbying In Q1 2008 219
17 Appendix 220
17.1 Research Methodology 221
17.2 Secondary Research 221
17.3 Primary Research 221
17.4 Models 222
17.5 Forecasts 222
17.6 Expert Panels 222
17.7 GlobalData Consulting 222
17.8 Currency Conversion 223
17.9 Contact Us 224
17.10 Disclaimer 224

List of Tables

Table 1: Alcon, Inc., Key Information, 2011 16
Table 2: Alcon, Inc., SWOT Analysis, 2011 23
Table 3: Ophthalmic Devices (Cataract Surgery Devices), Global, Company Share by Revenue ($m), 2011 29
Table 4: Alcon, Inc., Ophthalmic Devices (Cataract Surgery Devices), by Region, Revenue ($m) and Market Share (%), 2011 30
Table 5: Alcon, Inc., Ophthalmic Devices (Cataract Surgery Devices), by Country, Revenue ($m) and Market Share (%), 2011 32
Table 6: Ophthalmic Devices (Glaucoma Surgery Devices), Global, Company Share by Revenue ($m), 2011 33
Table 7: Alcon, Inc., Ophthalmic Devices (Glaucoma Surgery Devices), by Region, Revenue ($m) and Market Share (%), 2011 34
Table 8: Alcon, Inc., Ophthalmic Devices (Glaucoma Surgery Devices), by Country, Revenue ($m) and Market Share (%), 2011 36
Table 9: Ophthalmic Devices (Intraocular Lens (IOL)), Global, Company Share by Revenue ($m), 2011 37
Table 10: Alcon, Inc., Ophthalmic Devices (Intraocular Lens (IOL)), by Region, Revenue ($m) and Market Share (%), 2011 38
Table 11: Alcon, Inc., Ophthalmic Devices (Intraocular Lens (IOL)), by Country, Revenue ($m) and Market Share (%), 2011 40
Table 12: Ophthalmic Devices (Refractive Surgery Devices), Global, Company Share by Revenue ($m), 2011 42
Table 13: Alcon, Inc., Ophthalmic Devices (Refractive Surgery Devices), by Region, Revenue ($m) and Market Share (%), 2011 43
Table 14: Alcon, Inc., Ophthalmic Devices (Refractive Surgery Devices), by Country, Revenue ($m) and Market Share (%), 2011 45
Table 15: Ophthalmic Devices (Vision Care), Global, Company Share by Revenue ($m), 2011 46
Table 16: Alcon, Inc., Ophthalmic Devices (Vision Care), by Region, Revenue ($m) and Market Share (%), 2011 47
Table 17: Alcon, Inc., Ophthalmic Devices (Vision Care), by Country, Revenue ($m) and Market Share (%), 2011 49
Table 18: Ophthalmic Devices (Vitreo Retinal Surgery Devices), Global, Company Share by Revenue ($m), 2011 50
Table 19: Alcon, Inc., Ophthalmic Devices (Vitreo Retinal Surgery Devices), by Region, Revenue ($m) and Market Share (%), 2011 51
Table 20: Alcon, Inc., Ophthalmic Devices (Vitreo Retinal Surgery Devices), by Country, Revenue ($m) and Market Share (%), 2011 53
Table 21: Alcon, Inc., Ophthalmic Devices, Global, Revenue ($m) and Market Share (%) by Category, 2011 55
Table 22: Alcon, Inc., Ophthalmic Devices, Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2011 57
Table 23: Alcon, Inc., Ophthalmic Devices, Australia, Revenue ($m) and Market Share (%) by Category, 2011 59
Table 24: Alcon, Inc., Ophthalmic Devices, China, Revenue ($m) and Market Share (%) by Category, 2011 61
Table 25: Alcon, Inc., Ophthalmic Devices, India, Revenue ($m) and Market Share (%) by Category, 2011 63
Table 26: Alcon, Inc., Ophthalmic Devices, Japan, Revenue ($m) and Market Share (%) by Category, 2011 65
Table 27: Alcon, Inc., Ophthalmic Devices, Other Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2011 67
Table 28: Alcon, Inc., Ophthalmic Devices, Europe, Revenue ($m) and Market Share (%) by Category, 2011 69
Table 29: Alcon, Inc., Ophthalmic Devices, France, Revenue ($m) and Market Share (%) by Category, 2011 71
Table 30: Alcon, Inc., Ophthalmic Devices, Germany, Revenue ($m) and Market Share (%) by Category, 2011 73
Table 31: Alcon, Inc., Ophthalmic Devices, Italy, Revenue ($m) and Market Share (%) by Category, 2011 75
Table 32: Alcon, Inc., Ophthalmic Devices, Spain, Revenue ($m) and Market Share (%) by Category, 2011 77
Table 33: Alcon, Inc., Ophthalmic Devices, United Kingdom, Revenue ($m) and Market Share (%) by Category, 2011 79
Table 34: Alcon, Inc., Ophthalmic Devices, Other Europe, Revenue ($m) and Market Share (%) by Category, 2011 81
Table 35: Alcon, Inc., Ophthalmic Devices, Middle East and Africa, Revenue ($m) and Market Share (%) by Category, 2011 83
Table 36: Alcon, Inc., Ophthalmic Devices, North America, Revenue ($m) and Market Share (%) by Category, 2011 85
Table 37: Alcon, Inc., Ophthalmic Devices, Canada, Revenue ($m) and Market Share (%) by Category, 2011 87
Table 38: Alcon, Inc., Ophthalmic Devices, United States, Revenue ($m) and Market Share (%) by Category, 2011 89
Table 39: Alcon, Inc., Ophthalmic Devices, South and Central America, Revenue ($m) and Market Share (%) by Category, 2011 91
Table 40: Alcon, Inc., Ophthalmic Devices, Brazil, Revenue ($m) and Market Share (%) by Category, 2011 93
Table 41: Alcon, Inc., Ophthalmic Devices, Other South and Central America, Revenue ($m) and Market Share (%) by Category, 2011 95
Table 42: Alcon, Inc., Key Employees 96
Table 43: Alcon, Inc., Other Locations 98
Table 44: Alcon, Inc., Deals Volume Summary, 2007 to 2012 103
Table 45: Alcon, Inc., Deals Summary By Region, 2007 to 2012 104
Table 46: Alcon, Inc., Deals Summary, 2007 to YTD 2013 105
Table 47: IRIDEX Enters Into Licensing Agreement With Alcon 106
Table 48: Alcon Enters Into Licensing Agreement With Advanced Medical Optics 107
Table 49: Advanced Medical Optics Enters Into Licensing Agreement With Alcon 108
Table 50: Novartis Completes Acquisition Of Remaining 23% Stake In Alcon 109
Table 51: Novartis Completes Acquisition Of Additional 52% Stake In Alcon From Nestle 111
Table 52: Alcon Completes Acquisition Of Optonol 114
Table 53: Alcon Acquires Additional 17.6% Stake In WaveLight 116
Table 54: Novartis Acquires 25% Stake In Alcon From Nestle 117
Table 55: USD to Local Currency, Average Exchange Rate, 2011 223

List of Figures

Figure 1: Ophthalmic Devices(Cataract Surgery Devices), Global, Market Share (%), 2011 29
Figure 2: Alcon, Inc., Ophthalmic Devices (Cataract Surgery Devices), by Region, Market Share (%), 2011 30
Figure 3: Alcon, Inc., Ophthalmic Devices (Cataract Surgery Devices), by Country, Market Share (%), 2011 31
Figure 4: Ophthalmic Devices(Glaucoma Surgery Devices), Global, Market Share (%), 2011 33
Figure 5: Alcon, Inc., Ophthalmic Devices (Glaucoma Surgery Devices), by Region, Market Share (%), 2011 34
Figure 6: Alcon, Inc., Ophthalmic Devices (Glaucoma Surgery Devices), by Country, Market Share (%), 2011 35
Figure 7: Ophthalmic Devices(Intraocular Lens (IOL)), Global, Market Share (%), 2011 37
Figure 8: Alcon, Inc., Ophthalmic Devices (Intraocular Lens (IOL)), by Region, Market Share (%), 2011 38
Figure 9: Alcon, Inc., Ophthalmic Devices (Intraocular Lens (IOL)), by Country, Market Share (%), 2011 39
Figure 10: Ophthalmic Devices(Refractive Surgery Devices), Global, Market Share (%), 2011 41
Figure 11: Alcon, Inc., Ophthalmic Devices (Refractive Surgery Devices), by Region, Market Share (%), 2011 43
Figure 12: Alcon, Inc., Ophthalmic Devices (Refractive Surgery Devices), by Country, Market Share (%), 2011 44
Figure 13: Ophthalmic Devices(Vision Care), Global, Market Share (%), 2011 46
Figure 14: Alcon, Inc., Ophthalmic Devices (Vision Care), by Region, Market Share (%), 2011 47
Figure 15: Alcon, Inc., Ophthalmic Devices (Vision Care), by Country, Market Share (%), 2011 48
Figure 16: Ophthalmic Devices(Vitreo Retinal Surgery Devices), Global, Market Share (%), 2011 50
Figure 17: Alcon, Inc., Ophthalmic Devices (Vitreo Retinal Surgery Devices), by Region, Market Share (%), 2011 51
Figure 18: Alcon, Inc., Ophthalmic Devices (Vitreo Retinal Surgery Devices), by Country, Market Share (%), 2011 52
Figure 19: Alcon, Inc., Ophthalmic Devices, Global, Category Revenue Share (%), 2011 54
Figure 20: Alcon, Inc., Ophthalmic Devices, Global, Market Share (%) by Category, 2011 55
Figure 21: Alcon, Inc., Ophthalmic Devices, Asia-Pacific, Category Revenue Share (%), 2011 56
Figure 22: Alcon, Inc., Ophthalmic Devices, Asia-Pacific, Market Share (%) by Category, 2011 57
Figure 23: Alcon, Inc., Ophthalmic Devices, Australia, Category Revenue Share (%), 2011 58
Figure 24: Alcon, Inc., Ophthalmic Devices, Australia, Market Share (%) by Category, 2011 59
Figure 25: Alcon, Inc., Ophthalmic Devices, China, Category Revenue Share (%), 2011 60
Figure 26: Alcon, Inc., Ophthalmic Devices, China, Market Share (%) by Category, 2011 61
Figure 27: Alcon, Inc., Ophthalmic Devices, India, Category Revenue Share (%), 2011 62
Figure 28: Alcon, Inc., Ophthalmic Devices, India, Market Share (%) by Category, 2011 63
Figure 29: Alcon, Inc., Ophthalmic Devices, Japan, Category Revenue Share (%), 2011 64
Figure 30: Alcon, Inc., Ophthalmic Devices, Japan, Market Share (%) by Category, 2011 65
Figure 31: Alcon, Inc., Ophthalmic Devices, Other Asia-Pacific, Category Revenue Share (%), 2011 66
Figure 32: Alcon, Inc., Ophthalmic Devices, Other Asia-Pacific, Market Share (%) by Category, 2011 67
Figure 33: Alcon, Inc., Ophthalmic Devices, Europe, Category Revenue Share (%), 2011 68
Figure 34: Alcon, Inc., Ophthalmic Devices, Europe, Market Share (%) by Category, 2011 69
Figure 35: Alcon, Inc., Ophthalmic Devices, France, Category Revenue Share (%), 2011 70
Figure 36: Alcon, Inc., Ophthalmic Devices, France, Market Share (%) by Category, 2011 71
Figure 37: Alcon, Inc., Ophthalmic Devices, Germany, Category Revenue Share (%), 2011 72
Figure 38: Alcon, Inc., Ophthalmic Devices, Germany, Market Share (%) by Category, 2011 73
Figure 39: Alcon, Inc., Ophthalmic Devices, Italy, Category Revenue Share (%), 2011 74
Figure 40: Alcon, Inc., Ophthalmic Devices, Italy, Market Share (%) by Category, 2011 75
Figure 41: Alcon, Inc., Ophthalmic Devices, Spain, Category Revenue Share (%), 2011 76
Figure 42: Alcon, Inc., Ophthalmic Devices, Spain, Market Share (%) by Category, 2011 77
Figure 43: Alcon, Inc., Ophthalmic Devices, United Kingdom, Category Revenue Share (%), 2011 78
Figure 44: Alcon, Inc., Ophthalmic Devices, United Kingdom, Market Share (%) by Category, 2011 79
Figure 45: Alcon, Inc., Ophthalmic Devices, Other Europe, Category Revenue Share (%), 2011 80
Figure 46: Alcon, Inc., Ophthalmic Devices, Other Europe, Market Share (%) by Category, 2011 81
Figure 47: Alcon, Inc., Ophthalmic Devices, Middle East and Africa, Category Revenue Share (%), 2011 82
Figure 48: Alcon, Inc., Ophthalmic Devices, Middle East and Africa, Market Share (%) by Category, 2011 83
Figure 49: Alcon, Inc., Ophthalmic Devices, North America, Category Revenue Share (%), 2011 84
Figure 50: Alcon, Inc., Ophthalmic Devices, North America, Market Share (%) by Category, 2011 85
Figure 51: Alcon, Inc., Ophthalmic Devices, Canada, Category Revenue Share (%), 2011 86
Figure 52: Alcon, Inc., Ophthalmic Devices, Canada, Market Share (%) by Category, 2011 87
Figure 53: Alcon, Inc., Ophthalmic Devices, United States, Category Revenue Share (%), 2011 88
Figure 54: Alcon, Inc., Ophthalmic Devices, United States, Market Share (%) by Category, 2011 89
Figure 55: Alcon, Inc., Ophthalmic Devices, South and Central America, Category Revenue Share (%), 2011 90
Figure 56: Alcon, Inc., Ophthalmic Devices, South and Central America, Market Share (%) by Category, 2011 91
Figure 57: Alcon, Inc., Ophthalmic Devices, Brazil, Category Revenue Share (%), 2011 92
Figure 58: Alcon, Inc., Ophthalmic Devices, Brazil, Market Share (%) by Category, 2011 93
Figure 59: Alcon, Inc., Ophthalmic Devices, Other South and Central America, Category Revenue Share (%), 2011 94
Figure 60: Alcon, Inc., Ophthalmic Devices, Other South and Central America, Market Share (%) by Category, 2011 95
Figure 61: Alcon, Inc., Deals Volume Summary, 2007 to 2012 103

Companies Mentioned
Abbott Medical Optics, Inc.
Bausch and Lomb Incorporated
Carl Zeiss AG
Aurolab
New World Medical, Incorporated
iScience Interventional, Inc.
Molteno Ophthalmic Limited
Eagle Vision, Inc.
Hoya Corporation
STAAR Surgical Company
Appasamy Associates
Medennium

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Rayner Intraocular Lenses Limited - Product Pipeline Analysis, 2014 Update

Rayner Intraocular Lenses Limited - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

Summary Intraocular Lenses Limited (Rayner) is a medical device company. The company manufactures intra ocular lens. Its products include sulcoflex which includes sulcoflex aspheric, sulcoflex toric and ...

Signature Eyewear, Inc. (Symbol:SEYE) SWOT Analysis, Strategy, Revenues and Profits

Signature Eyewear, Inc. (Symbol:SEYE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

St. Shine Optical Co., Ltd. (Symbol:1565) SWOT Analysis, Strategy, Revenues and Profits

St. Shine Optical Co., Ltd. (Symbol:1565) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

New Look Eyewear Incorporation

October 2014 $ 55

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.